Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 14 Oct 2026 for Summit Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleBhaskar Anand
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Bhaskar Anand: trading record in brief
This profile gathers the share dealings of Bhaskar Anand across 2 companies, led by Reata Pharmaceuticals Inc and Summit Therapeutics Inc. Between 3 January 2022 and 8 October 2026, the trades on record add up to 13 filings.
Sales make up the whole of the open-market record (5 sales, €250k). The rest of the record consists of 6 share grants and 1 option exercise.
On 14 October 2026 came the latest disclosure, a share grant in Summit Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bhaskar Anand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
100,000 shares0Common StockSEC:0001890784-26-000006:0
26,680 shares@ US$18.7448.7% of flowCommon StockSEC:0001890784-25-000005:0
22,026 shares@ US$22.7051.3% of flowCommon StockSEC:0001599298-24-000135:0
24,089 sharesClass A common stockSEC:0000899243-23-019532:0
406 shares@ US$169.2022.1% of flowClass A common stockSEC:0001209191-23-048601:0
193 shares@ US$169.05510.3% of flowClass A common stockSEC:0001209191-23-046276:0
1,562 shares@ US$27.3213.6% of flowClass A common stockSEC:0001209191-23-037802:0
950 shares@ US$85.983326.0% of flowClass A common stockSEC:0001209191-23-030181:0
165 shares@ US$84.584.5% of flowClass A common stockSEC:0001209191-23-017248:0
820 shares@ US$87.4723.4% of flowClass A common stockSEC:0001209191-23-016281:0
3,000 shares0Class A common stockSEC:0001209191-23-014817:0
8,250 shares0Class A common stockSEC:0001209191-23-000851:0
12,500 shares0Class A common stockSEC:0001209191-22-001640:0
13 of 13 declarations
